Sponsors

Rickettsia monoclonal antibody

ViroStat has released a new monoclonal antibody to the rickettsiae LPS. It is reactive with all members of the spotted fever group of rickettsiae. It does not cross react with the typhus group (R. typhi or R. prowazekii). This new antibody functions in enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assay (IFA) and may also function in other rapid test formats.

Rickettsia rickettsii is an obligate intracellular Gram-negative bacterium that can infect humans and other invertebrates. The most common human disease is spotted fever. Transmission occurs from the bite of various infected arthropods, the most common being the American dog tick and the Rocky Mountain wood tick. Typical symptoms are fever, headache and a rash. Prompt treatment with doxycycline is recommended.

www.virostat-inc.com

Latest Issues

Introduction to bone marrow trephine

Online
9 December, 2025

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026